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Liposomes can be loaded with weak acids an  bases, which exist in solutions in equilibrium with membrane permeable uncharged form, using 
various gradients across their membranes. Because in some cases the estimated rug concentration in the loaded liposomes exceeds their aqueous 
solubility we investigated the physical state of the liposome ncapsulated anticaneer drug Doxorubicin. X-Ray diffraction, electron microscopy. 
and test tube solubility experiments have shown that upon encapsulation the drug molecules form a gel-like phase 
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1. INTRODUCTION 
Several reports have shown that weak acids and bases 
can be loaded into preformed liposomes by the applica- 
tion of ionic gradients across the liposome bilayer [1-4]. 
For example, high concentrations of particular mole- 
cules can be accumulated into liposomes upon their 
addition into the external medium in the presence of a 
pH gradient between the inside and outside of the li- 
posome [1-3]. Similar distributions of various fluores- 
cent probes have been used to measure the internal pH 
of various cells and organelles and results were ex- 
plained in terms of the Henderson-Hasselbach equation 
[1-3,5,6]. 
These same methods can be applied also for the load- 
ing of drugs into iiposomes. For instance, doxorabicin, 
an anticancer drug, which is a weak amphiphatic base 
(pK~ = 8.25), has been loaded into liposomes where the 
pH of the inside was 4 and the pH of the outside solu- 
tion was 7 [3]. Unfortunately the gradients are not very 
stable and the drug molecules leak out, with half-lives 
ranging from minutes to hours, depending on the bi- 
layer composition. Moreover, lowering the outside pH 
results in re-equilibration and further drug leakage [3]. 
In order to overcome these shortcomings, we have 
used a method of ammonium sulfate gradient loading. 
With this method, the drug is not released after li- 
posomes are loaded and its encapsulation is quite stable 
[7]. In fact, the drug remains encapsulated even after 
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relaxation of the ammonium sulfate gradient and its 
release is not sensitive to the external pH. The internal 
drug concentration, estimated from measurements of 
liposome internal volume, exceeded the solubility of the 
drug severalfold. We attribut~i this phenomenon, by 
analogy with the concept of chemical potential gradient 
loading with a molecular sink on one side of the semi- 
permeable membrane (so-called 'black-hole' loading), 
to the formation of a (semi)solid phase in the liposome 
interior. 
In this paper, we further investigate the reasons for 
the unusually efficient loading of doxorubiein into ii- 
posomes with a salt gradient across the bila2/er mem- 
brane. In particular, we use cryo-electron microscopy 
and X-ray diffraction to study the physical phase of 
doxorubicin in the interior of vesicles loaded by ammo- 
nium sulfate gradients. 
2. MATERIALS AND METHODS 
Small unilamellar v~icles (SUV). ~,ith homogeneous size di tribu- 
tion around 85 nm, were prepared bymicroflaidlzation (5passes at 
1,000 atm and 50°C) or by extrusion [4] of a dispersion ofmultilamel- 
lar vesicles (MLV, composition: hydrogenated soy lecithin/choles- 
terol/PEG-lipid na tool ratio 57:38:5) in 155 mM ammonium sulfate. 
pH 5.5. The PEG-lipid consists of pol2iethylen¢ glycol (hi,, = 2.000 
De) covalently attached to istcaroyl phosphatidylethanolamine. We 
have chosen a lipid composition containing polymer-bearing lipid to 
increase liposome stability against aggregation [8.9] which is often a 
problem in work with uncharged lipid bilayers. This. the so-called 
steric stabilization.,.as opposed t  charge stabilization, was extensively 
described elsewhere [9.10]. Because the ammonium sulfate gradient 
loading can operate at nominail), the same. pl-! inside and oa'.side of 
liposomes, the external medium was exchanged for isotonic sucrose 
(pH 5.5) and liposomes were mixed 'with drug solution: doxorubicin- 
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HCI at 6 mg/ml in 10% sucrose at pH = 5,5, At'ter i h incubation at 
60°C the samples were cooled and assayed for encapsulation effi- 
ciency. Typic.ally, loading efficieneies of around 95%, as measured by 
gel chromatography (dcsalting Pierce Excellulose GF5 columns, pec- 
trophotometric detection of doxorubicin), were achieved and drug 
concentration was 3 mg/ml at a lipid concentration f 30 raM. 
The loading efficiency did not depend on the presence of the PEG- 
lipid, negative charge, or the acyl chains composition of the lecithin. 
The apparent concentration o1" the doxorubicin in the liposome aque- 
ous phase was almost independent of liposome size and lamcllarity. 
The drug-to-lipid ratio, however, was dependent on llposom¢ size and 
lamellarity (data not shown). 
For eryo-~leetron microscopy, thin films were prepared from the 
suspensions by dipping a bare 700 mesh hexagonal grid in the suspen- 
sion and blotting with filter paper after withdrawal, and the thin films 
were vitrified by plunging into melting ethane [11]. The vitrified thin 
films were stored under liquid nitrogen and observed in a Gatan 626 
cry, o-holder at - 170°C with a Philips CM 12 microscope. Micrographs 
were taken at 120 kV under low-dose conditions. 
For X-ray diffraction experiments, empty and leaded llposomes 
were pelleted (230,000 × g, 10 h) and sealed in thin walled glass 
capillary tubes. Specimens were mounted in a point collimation X-ray 
camera and diffraction patterns were recorded on K dak DF-F-5 X- 
ray film in a flat plate film cassette as described previously [12,13]. 
Liposome pellets could be redisporsed with no c ange in particle size, 
as measured by dynamic light scattering (Coulter N 4SD) or loss of 
drug encapsulation. X-ray patterns were also recorded from doxorubi- 
cin-HCl powder and mixtures ofdoxorubicin at30 mg/ml with appro- 
priate salts atconcentrations i  the range 0.1-0.5 M. 
3. RESULTS AND DISCUSSION 
Several doxorubicin-salt mixtures were prepared in 
a test tube and studied visually and in an optical micro- 
scope. 
Flocculation occurred immediately upon mixing a 
doxorubicin solution (30 mg/ml in 10% sucrose) with 
ammonium sulfate crystals. Moreover, after heating to 
600C to liquify the system, a homogeneous gel formed 
uoon cooling. Because this phase was optically iso- 
tropic, quite viscous, and exhibited thixotropic behav- 
ior, we refer to this semi solid phase as a 'gel'. At a salt 
concentration of  0.155 M the ammonium sulfate gel 
melted at 55°C. An observed hysteresis of  7-8°C, at 
cooling rate 10°C/min, indicates that this is a strong 
first-order phase transition. Similar behavior was ob- 
served also when Na2SO4 was used. As the ammonium 
stilt'ate concentration was increased from 0.1 to 0.5 M, 
the phase transition temperature linearly increased from 
54 to 60°C. 
At room temperature and pH 5.5 the maximum 
amount of doxorubicin-HCl that could be dissolved in 
sucrose solution was about 35 mg/ml. However, from 
liposome internal volume measurements and from the 
encapsulation efficiency we estimated that the doxoru- 
bicin concentration i liposomes was over 100 mg/ml 
and this probably indicates the presence of  a phase 
change, Therefore X-ray and EM experiments were per- 
formed to determine the structure of  the doxorubicin 
trapped in the liposom~s. 
Cryo-eleetron microscopy [11] of  empty liposomes 
showed round structures with pale membranes, typical 
Fig. 1. Cryo-elcetron micrograph of extruded vcsiel6~ without loaded 
drug. Vesicles vitrified in a thin film can be observed superimposed due 
to the 'through vision' of the method. The lipid I~ilayer can be resolved 
(arrowheads) using a defocus of 1.5/~m. Bar = 100 nm. 
o f  S UV's (Fig. 1). In contrast SUV's containing doxoru- 
bicin were ellipsoidai and contained ark stripes, usu- 
ally aligned with the major semiaxis of the ellipse (Fig. 
2). These core strttctures were mostly present as a single 
rod, giving the appearance o f  a coffee bean. Occasion- 
ally two or more core structures were observed in a 
single l iposome or alternatively 'V'- and 'Y'-shaped 
cores were observed. The core structure seemed to be 
composed of  longitudinal rods or sheets (periodicity of  
the order of 27 A) but this can only be observed in a few 
areas where parts of  a core have a favourable orienta- 
tion to the electron beam. 
X-ray diffraction patterns were recorded from several 
forms of doxorubiein: dry powder, in sucrose solutions 
with and without ammonium sulfate and sodium sul- 
fate, and loaded and empty liposomes. X-ray patterns 
from the dry doxorubicin powder contained a series of  
sharp diffraction rings. The spacings of the darkest of  
these rings were: 20.0, 10.1, 8.5, 7.6, 6.6, 5.9, 5.3, 4.8, 
4.5, and 4.3 A. 
Diffraction patterns from SUV's containing doxoru- 
bicin, loaded by the ammonium sulfate gradient 
method, contained a single sharp reflection at 27 A, 
similar to the periodicity observed by EM for the core 
structure within the drug loaded liposomes (Table I). In 
control experinaents, diffraction patterns from SUV's 
made in the absence of  doxorubiein gave 3 weak reflec- 
tions at 83, 55, and 41.5 A. These reflections index as 
256 
Volume 312. number 2,3 FEBS LETI 'ERS November 1992 
'" .L :" ~ ~-'~. : :,:~;" ', ." ~>¢~;~". '  .e~.~. "-~'.-' ,f '. 
. . . . .  . ' T~"  ~: ~;:~,-'~¢~i;~ 
"_.., . - . .  ... • .  , '  . ' r .  , . . .  . " , .  ' " ;  ~ " . . -  ; " L ' . ; "~ :'~.!. 
:~ . " :  " " - : ' -  - ; "  ~ 'T : :  " . ;~ .~ ' ;~q, '~ . .  
7-(, ~ ." >~' :  ~ . ~ . "  - - . ." . - . .  ".-?,.~,'..-' 
~: ' "  :~  % :'~' - "  :'~ " "  "~2 
~ " ' • :~ ' . : .  "~ . - '  • . " .'7 ~, r7  ' . . . .  " " . .a .  
• , ....~. °, . . . ...! ~-~,:,. :~ .. : ..-, ~'~ 
• 'd. ; . ". . .  " -~ ' "~ ' . . ,3 . .~  ,. " ,  :. ~. ":.~.fi,'! 
- . . . : .: .~..: ' ,  .~ .  4 ~ . . . , :  . , ,  . . ,  ... 
,. . . ,  . ,5 .~ ' : ?  , . .  , ", . . .~ . ,  ~ 
t . , - - - - -  . . . .  • ~- .  ,~  . t  , . ,  • " , ., . .  . ~ • , .~ ,~,~.  
• ", " "  e . "  ' . .  ~ , , , . .  , , . . . .  . , . ;?~!'t ' .¢.  
• ' " ~ -. . :  ' ~" ?~,!'." :' 5 " '  9 . , .  -~ • ' - ' '~  
i" ~ " ' . .  ( " . "  . ~ '." " "  "0"  " " ; "~: . " - " : .•¢ ' "  
• . - .  . . . .  ,, .--. . .  :~ , -~r~;  
, • • • . - . • - ; . . , , .~ ,~. .c :~;  ~t! : .~.  
• ... . • . ......~.~ ~.,~.(.-.~:, 
• • ~ " ' ' ...... :'~,:~!~'~i! :: ~ ~ , ,?:~. ~,~,??. ~ ,.~'?~' 
. . . .  ! ~' ~ .:i-~ ":i " '~. . ; :  .-,~;¢~: ~ 
. . . . .  • . "  . ~ ' , ;  :~ ,~ ' , ,  . , : . . ' e . . . ; ,19  
• ": " - , . . " .e : (~.~ ' '  • • -.~ . : " - ' , . .~-~:~- -~. -M- .  
. . . .  . . ,  %:~.,.,..f',.. -  
• ' , :  " . . . . . . .  : i . ¢'::" ........ .- : . . .  : .. " ' .":i.'-"..~.i.'. !7 .~: : : , : ; : :~:"2:1  . . . .  • " . -  ' • " ' . - '  ' L  . . . . .  - 
,:, ~: - . .  ~ • .. • , , . . . . , : . .  , . . . . : .&-  
. ~ -'.,,:,;~, 
: t ' - "  "" ' - ' . . :  • ' " " " 
: . "  , ,.:... : ~; r .. ,:.:-. 
~" ' " ' ' " " " . . . . .  q:~ .:;,i:' ~:i~:;:.'.'...: 
~ ' - :  . . . . .  : . . ,  , , , , :~ : : :~ ' .  ~ , , . ,  
, . . . . . . .  , .< . .~. .~ 
• . • . . . .  : <~-. .~;~. . .  .~ 
- . . . . .  i • ." ...'::' • . . . . . .  .,-. • ..... ,,-~,.~ .~, :; i 
:..:~, , .... :~  ~: :  , . , ~ " , i ~  ~ ~ "  . .  
I 
t 
- .  ~ • ~.~ ~__7_ . j¢ .  ~ ..~,..,~ 
"" t ! . , "  
.> ,  
• .. : ;  ... 
i "  
i:~," . ' -  . . . .  '?"" i - 
i , ' :~ ~ " . " "c~ '-" 
K!2;~:: :" . ' ,  .... i . ' -  
Fig. 2. Cryo.01eetron microscopy of drug-loaded vesicles. Vesicles with a core can bo observed as well as 'empty' vesicles (a). In larger eom structures 
(b) gross-striations are visible with a periodicity of about 26 A. These liposomes were prepared by microfluidization which causes the formation 
of a small fraction of dlsc-like micelles which can be seen as dark rods (Frederik and Lasic. in preparation). Bar = 100 nm. 
orders 2, 3, and 4 o f  a lamel lar  repeat  per iod of  about  
166 A. This lamel lar repeat  per iod was  similar to that  
recor: led f rom fully hydrated  MLV o f  stearoyloleyl  
phosphat idylehol ine/cholestero l  (2:1) contain ing 4 
reel% PEG 2000 lipid [9] and thus undoubted ly  arose 
f rom a small amount  o f  MLVs  in the sample.  
Di f f ract ion patterns o f  30 mg/ml  doxorub ic in  in 10% 
sucrose with either 250 mM Na:SO4 or  (NH4).,SO~ gave 
a single sharp reflection at 27 A. In contrast ,  30 mg/ml  
solut ion o f  doxorubic in  in 10% sucrose with no added 
salt gave no discrete reflections. 
All o f  these samples were opt ical ly isotropic and  no 
birefr ingence was observed.  Calculat ions of  shape 
changes at eomtant  surface area and  tak ing into ae- 
count  heterogeneity of  the vesicles indicate that the el- 
l ipsoidal structures are pre la te  and not  oblate ell ipsoids. 
This implies that  the gel part icles are one-d imens ional  
Table I 
Small angle X-ray reflections from different samples 
Sample Reflections (A) 
Doxorabicin-HCl 20.0, 10.1, 8.5, 7,6, 6.6 
Crystalline 5.9, 5.3, 4.8, 4.5, 4.3
Empty llposom~s 83, 55, ~1.5 
Loaded liposomes 27 
3% Don solution none 
3% Dox-(NHD:SO4 27 
3% Dox-Na~.SO4 27 
rods rather  than two-d imens ional  sheets, in agreement  
with EM observat ions.  
The  doxorubic in aggregat ion is also suppor ted  by 
complete  quenching o f  its f luorescence and the increase 
in the 550/470 nm absorbance  rat io in the electron ab- 
sorpt ion spectra [14]. This rat io increased f rom 0.19 in 
the solut ion o f#M doxorub ic in  in 0.15 M NaCI  to 0.53 
in the l iposome suspension. Both  changes are related to 
the interact ions o f  g electrons o f  the p lanar  aromat ic  
anthracycl ine rings which over lap when stacked in the 
aggregated phase [14]. 
The  EM images indicate that  the ammonium sulfate 
gradient  procedure loads doxorub ic in  into SUV's ,  pro-  
ducing an e lectron-opaque band within the l iposomc. 
The X - ray  dif fract ion exper iments  indicate that  the con- 
tents o f  the l iposome have a similar s~ructure to that  o f  
'gels'  obta ined by the addit ion o f  ammonium sulfate or 
sod ium sulfate to doxorubic in  solut ion.  That  is, our  
results provide direct evidence that  the doxorubic in  is 
incorporated into l iposomes in a gel. l ike phase, and is 
not  adsorbed into/onto the bilayer. The  stabil ity of  these 
doxorubie in-eonta in ing SUV's  was  demonst ra ted  by 
their abil ity to withstand very large centr i fugal  forces 
w i thout  changing their average size. This  result is con- 
sistent with previous observat ions  of  "gelosomes',  li- 
posomes  with a gelatinized inter ior [15], as well as with 
theoret ical  predict ions [16]. 
In  conclusion, we have shown that  the high encapsu-  
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lation efficiency of  doxorubic in into l iposomes, ob-  
tained by the ammonium sulfate gradient loading 
method,  is due to the format ion o f  a gel-like precipitate 
in the l iposome interior. 
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